Annotated abstract

Pill version of obesity jab is approved in US, with UK decision pending

bmj · 2026-01-02 · canonical JSON source

3 visible annotations · policy: published · automated confidence ≥ 75.00%

Document resource

US officials have approved a daily pill version of Novo Nordisk’s injectable obesity drug Wegovy (semaglutide), opening the door to even more patients taking it.